Indonesia surrogacy law: permissibility, prohibitions and commercial versus altruistic models
Short answer
Short answer. As at 23 October 2026, Indonesia provides no lawful clinical pathway for surrogacy. Article 58 of Law No. 17 of 2023 on Health limits assisted reproduction to legally married couples and requires an embryo made from their own sperm and ovum to be transferred into the uterus of the wife who provided the ovum. Article 45(5) of Minister of Health Regulation No. 2 of 2025 expressly prohibits providers from offering womb-lending services. No separate exception exists for unpaid family or altruistic arrangements.
This conclusion concerns the regulated medical service and embryo-transfer rules. Private-contract enforceability, legal parentage, birth registration, nationality and cross-border recognition require separate analysis. A clinic’s offer, notarised contract, genetic link or payment arrangement is not legal authorisation.
Which rules control?
The principal statutory rule is Article 58 of Law No. 17 of 2023 on Health, in force since its promulgation on 8 August 2023. It provides that assisted reproduction may be carried out only by lawfully married couples; the fertilisation result must use the sperm and ovum of that couple and be placed in the uterus of the wife from whom the ovum originated; and the procedure must be performed by appropriately qualified medical professionals at designated health-service facilities. The article also says that reproductive-health services must comply with legislation and must not conflict with religious values.
Government Regulation No. 28 of 2024, in force from 26 July 2024, develops the framework. Article 111 requires medically established infertility in a legally married couple, use of their own gametes, and transfer into the wife’s uterus. Article 112(3) separately restricts transfer of surplus embryos into another woman’s uterus, including the listed situations of the embryo’s father’s death or divorce.
The more specific current rule is Minister of Health Regulation No. 2 of 2025, effective 20 February 2025. Article 45(5) prohibits providers from offering egg, sperm or embryo donation, donation of ovarian or testicular tissue, and womb-lending services. It replaced Minister of Health Regulation No. 43 of 2015; older articles describing only that regulation do not state the complete current position.
The instruments have different roles: the Law sets the boundary, the Government Regulation develops eligibility and embryo-handling rules, and the 2025 Ministerial Regulation expressly prohibits specified services and provides for provider sanctions.
What is prohibited in practice?
Here, surrogacy means an arrangement in which a woman carries a pregnancy for intended parents, usually after embryo transfer. The issue is not only the source of genetic material, but also where the embryo is implanted and whether a provider supplies a womb-lending service.
Where an embryo created for a couple is transferred to another woman to carry, the arrangement conflicts with the requirement that the embryo be placed in the uterus of the wife from whom the ovum originated. Article 112(3) of Government Regulation No. 28 of 2024 also prohibits implanting surplus embryos in another woman. Article 45(5) of Regulation No. 2 of 2025 expressly prohibits the assisted-reproduction service of “pinjam rahim” (womb lending). These rules leave no statutory route for a clinic to present gestational surrogacy as an authorised assisted-reproduction service.
The regulated service also excludes donated eggs, sperm and embryos, listed separately from womb lending. Using the intended parents’ own gametes does not cure the problem: it may meet the genetic-material condition but not the requirement to implant the embryo in the wife’s own uterus.
Traditional surrogacy, in which the carrier’s own ovum is fertilised, likewise conflicts with the couple-own-gametes and wife’s-uterus requirements; the prohibition is not limited to gestational arrangements.
The reviewed texts create no general surrogacy-licensing system, approval process for intended parents, or consent-based exception. Consent matters medically and ethically, but does not legalise a prohibited service.
The narrow assisted-reproduction route that remains
Indonesia’s rules do not prohibit all assisted reproduction. They set conditions for the permitted service. Under Article 111 of Government Regulation No. 28 of 2024, the service is directed to a legally married couple whose medical examination establishes infertility. The sperm and ovum must come from that couple, and the resulting embryo must be placed in the uterus of the wife from whom the ovum came. Article 58 of the 2023 Health Law adds that the procedure must be carried out by medical professionals with the required expertise and authority at designated health-service facilities.
Article 45(2)–(3) of Regulation No. 2 of 2025 repeats the own-gametes and wife’s-uterus conditions and requires a marriage certificate or deed under applicable law. Article 46 limits service to designated hospitals and main clinics; Article 48 requires counselling and medical consent before treatment.
These conditions are cumulative. An infertility diagnosis does not authorise a third-party carrier; marriage does not authorise donor gametes; and a clinic licence does not legalise a prohibited method. Sex selection is also restricted, with a narrow exception to avoid sex-linked genetic disease; that exception is unrelated to surrogacy.
Before IVF, obtain written confirmation of the provider’s current designation, medical indication, gamete source, transfer plan, counselling and consent requirements, and surplus-embryo handling. Compliant IVF with transfer into the wife’s uterus is legally distinct from surrogacy.
Commercial and altruistic models: is there a difference?
The current assisted-reproduction rules do not distinguish between paid and unpaid womb-lending services. Article 45(5) prohibits the service itself; it does not say that the prohibition applies only where the carrier receives compensation, nor does it set out a safe harbour for a relative, friend or other volunteer. Government Regulation No. 28 of 2024 also prohibits the specified transfer of surplus embryos into another woman’s uterus without creating a payment-based exception.
Accordingly, an arrangement should not be described as lawful in Indonesia merely because it is called altruistic, reimburses only expenses, involves a sister or other relative, or contains no agency fee. If a clinic, doctor or other provider is asked to facilitate the transfer or provide a womb-lending service, the express service prohibition is directly relevant regardless of the label used by the parties.
Whether a wholly private, non-medical promise between adults attracts a specific statutory or criminal penalty is a separate question not fully answered by the cited health provisions. That uncertainty creates no lawful clinical route and does not make a private agreement enforceable.
Who may face regulatory sanctions?
Article 76 of Minister of Health Regulation No. 2 of 2025 provides for administrative sanctions against medical professionals, health professionals and health-service facilities that breach the specified provisions of Article 45(4)–(5), and Article 49(8)–(9) of the same Regulation. The listed sanctions are a written warning, an administrative fine, and/or revocation of the relevant licence or authorisation. Articles 77–79 describe a graduated approach to those sanctions, including written warnings and the circumstances in which fines or licence revocation may follow.
These are provider-facing administrative measures. The text does not say that the same Article 76 sanctions automatically apply to intended parents or to a surrogate solely because they are parties to an arrangement. Nor should a reader infer from this article that no other legal rule could apply to particular conduct. Any potential civil, administrative, professional or criminal exposure must be assessed against the actual facts and the relevant provisions.
Under Article 80(1), a breach may be identified through a complaint or monitoring and evaluation. Article 80(3) requires a complaint to be in writing, not intended to resolve a claim for compensation, and not previously reported and/or examined. Under Article 80(4), it must state the complainant’s full name, full address and contact details; the reported party’s full name and address; the alleged breach and when it occurred; the reasons for the complaint or a chronology; supporting facts, data or indications; and the witnesses and their roles. Article 81 directs the report to the Minister, governor, regent/mayor or designated official and requires the complainant’s identity to remain confidential except for law-enforcement purposes. This is a regulatory reporting route, not a procedure for resolving a compensation claim.
Private agreements do not authorise the procedure
The health regulations strongly obstruct surrogacy as an assisted-reproduction service but do not comprehensively govern every private contract. Indonesian civil-law scholarship argues that such an agreement may fail the Civil Code’s validity requirements, including lawful cause, because it conflicts with mandatory health rules and public-order or morality principles. This is academic analysis, not a binding judgment on a specific contract.
The safe conclusion is not to assume that a signed document creates an enforceable right to embryo transfer, pregnancy, payment, surrender of a child, or reimbursement. A notarised document, a private payment schedule, a penalty clause or a choice-of-law clause does not by itself authorise a medical service that national health rules prohibit. Nor does a promise by an agency or clinic guarantee that a court will enforce the agreement.
Before signing or paying, obtain advice from an Indonesian lawyer who can review the precise proposed acts, the identity and role of each party, any medical intervention, the governing-law clause, the intended place of performance, and the likely remedies if the arrangement fails. Ask the lawyer to distinguish contract validity from restitution or recovery of money already paid; one cannot assume that a potentially invalid agreement automatically resolves every financial claim.
A child’s status must be assessed separately
Permission to use a reproductive method and legal parentage are separate questions. The rules regulate assisted-reproduction services and embryo transfer, not a complete surrogacy parentage regime. Genetic links, the contract, the person who gives birth and the birth record may matter, but none is automatically decisive without examining family, civil-status and child-protection law.
The sources do not establish a dedicated procedure that automatically recognises the intended parents as the legal parents of a child born through surrogacy. They also do not justify a blanket claim that the child lacks rights or that registration can simply be refused. The child’s identity, birth registration, care, maintenance, nationality and best interests must be assessed separately from any question about whether the adults’ arrangement was permitted.
Do not promise that DNA alone establishes legal parentage, that a contract compels a child’s transfer, or that adoption is necessarily available. The result depends on the facts, Indonesian family and civil-registration law, and possible judicial interpretation. Protect the child’s identity and rights without implying that adults’ contractual expectations determine the outcome.
If a pregnancy or birth has already occurred, obtain advice before making representations to a civil registry, signing a parentage declaration, attempting to amend a birth record, or taking the child across a border. Accuracy and consistency of medical, birth and identity records are important; they must not be manipulated to make an arrangement appear authorised.
A foreign programme does not bypass Indonesian rules
Intended parents may consider a programme abroad or have an embryo or pregnancy connected with Indonesia and another country. This article does not decide the programme’s legality under foreign law; it addresses Indonesian rules and separate issues arising when parties, clinic, embryo, birth or recognition span jurisdictions.
A foreign clinic’s authorisation does not, by itself, establish that a procedure is permitted in Indonesia or that Indonesian authorities will recognise the resulting parentage. Conversely, the Indonesian assisted-reproduction rules should not be casually described as deciding every issue under the foreign country’s law. The law of the place where medical acts occur, the rules governing parentage and civil registration, and the law of the intended parents’ nationality or residence may all need to be considered.
Before proceeding, obtain written advice in each relevant jurisdiction on the lawfulness of the medical acts, legal parentage and birth registration, recognition of any foreign parentage order, the child’s nationality, and exit/entry documents. These are separate questions; a foreign clinic’s approval or a contract does not decide them automatically.
Practical decision matrix
The following matrix summarises the main decision points. It is not an approval tool and does not replace a fact-specific legal opinion.
| Proposed arrangement | Position under the rules reviewed | Practical response |
|---|---|---|
| IVF using the married couple’s own sperm and ovum, with embryo transfer to the wife from whom the ovum came | Potentially within the permitted assisted-reproduction framework, if all medical, provider, counselling and consent conditions are met. | Verify eligibility and the provider’s current designation in writing before treatment. |
| Another woman carries a pregnancy for the intended parents, using their embryo or her own ovum, whether paid or unpaid | Not an authorised assisted-reproduction service; womb lending is expressly prohibited, and using the carrier’s ovum conflicts with the own-gametes condition. | Do not book, pay for or ask a provider to arrange the procedure in Indonesia. |
| Use of donated eggs, sperm or embryos within the assisted-reproduction service | Expressly prohibited by Article 45(5) of Regulation No. 2 of 2025. | Do not assume a donor programme is lawful because the clinic offers it. |
| Transfer of a surplus embryo into another woman’s uterus | Prohibited by Article 112(3) of Government Regulation No. 28 of 2024. | Obtain specialist advice on lawful embryo storage and handling; do not transfer it to another woman. |
| Private, unpaid agreement with a relative, without a provider | No statutory safe harbour is identified. The cited rules do not resolve every possible private-law or criminal question. | Do not assume it is lawful or enforceable; obtain Indonesian civil-law advice before acting. |
| Child already born through a surrogacy arrangement | Parentage, registration, nationality and care require separate analysis; no automatic outcome is established here. | Prioritise the child’s identity and protection and obtain family-law, civil-registration and immigration advice. |
Before signing, paying or starting treatment
Use the following steps before making an irreversible commitment:
- Define the proposed acts. Identify who supplies the sperm and ovum, who will carry the pregnancy, where embryo creation and transfer will occur, which clinic or professional will participate, and where the birth is expected to take place.
- Separate the legal questions. Ask for written advice on medical-law compliance, contract enforceability, parentage, birth registration, nationality, travel and the consequences if the parties disagree. A positive answer on one issue does not settle the others.
- Check the provider. For a lawful IVF pathway, request evidence of the hospital’s or designated main clinic’s current ministerial approval, and confirm that the exact procedure is within the authorised service. A generic healthcare licence is not proof that a prohibited method is permitted.
- Check the medical conditions. Confirm the documented infertility indication, the source of each gamete, the intended transfer site, counselling, informed consent, and the arrangements for surplus embryos under current rules.
- Do not rely on labels. “Altruistic”, “family arrangement”, “reimbursement only”, “international programme” or “notarised agreement” does not itself create an exception.
- Keep a reliable record. Preserve the proposed contract, payment requests, clinic communications, consent forms, medical records and written legal advice. Do not alter or backdate documents to fit a desired legal position.
If a third party would carry the pregnancy, pause payments and treatment in Indonesia. Ask an Indonesian lawyer to address Article 45(5) and the Article 112 embryo-transfer rule directly, rather than relying on a general IVF opinion.
Immediate steps if the process has started
Do not assume that signing a contract, paying an agency or completing an embryo-creation step makes the remaining steps lawful. Equally, do not assume that the answer is simply to abandon a pregnancy or disregard the child’s needs. The next steps depend on whether treatment has occurred, where the embryo is stored, whether a pregnancy exists, which providers are involved, and whether a child has already been born.
Preserve original documents and payment records. Obtain independent Indonesian legal advice promptly, and if treatment is ongoing, ask the treating provider for a medically safe plan that does not involve a prohibited transfer. The clinician should explain lawful options for care and embryo storage under the current rules. Avoid self-directed medical action or any attempt to move an embryo or child across borders without appropriate advice and authorisations.
If a child has been born, prioritise immediate care, accurate birth documentation and the child’s legal identity. Obtain separate advice on the civil registry, parentage, nationality and any necessary travel or immigration steps. Do not use false statements, altered documents or informal payments to try to resolve registration difficulties. If there is a dispute, a lawyer should assess available lawful civil, administrative or judicial routes based on the actual record.
Practical conclusion and points to confirm
The national framework is clear on the core medical point: assisted reproduction uses a legally married couple’s own gametes and transfer into the wife’s uterus; Minister of Health Regulation No. 2 of 2025 expressly prohibits provider womb-lending services. No commercial or altruistic exception appears. Private agreements, parentage and cross-border recognition are more fact-sensitive and must not be conflated with the medical-service prohibition.
This guide relies on the linked legislation and limited academic commentary. It is not an exhaustive review of Indonesian judgments, local practice, family law or foreign law. Reconfirm current law before acting, especially if embryos, pregnancy, birth or cross-border movement are involved.
Bottom line: do not describe a surrogacy or womb-lending programme offered in Indonesia as an authorised assisted-reproduction service, whether paid or unpaid. The health rules reviewed do not fully resolve every wholly private, non-medical agreement; obtain Indonesian legal advice before acting. For IVF within the permitted framework, verify every condition with the designated provider. If an arrangement already exists or a child has been born, obtain case-specific advice on provider conduct, contract claims, parentage, registration, nationality and child protection.
Sources and points to confirm
Primary legal texts are prioritised. The full text of Government Regulation No. The academic papers are commentary, not binding authority.
- S001. Law of the Republic of Indonesia No. 17 of 2023 on Health (official English translation)
- S002. Peraturan Pemerintah Nomor 28 Tahun 2024 — official BPK legal record
- S003. Peraturan Pemerintah Nomor 28 Tahun 2024 — full text in a secondary legal database
- S004. Peraturan Menteri Kesehatan Nomor 2 Tahun 2025 — official BPK PDF
- S005. Peraturan Menteri Kesehatan Nomor 2 Tahun 2025 — official BPK legal record
- S006. Legal Certainty for Children Born Through Surrogacy in Indonesia: A Normative Juridical Analysis (2026)
- S007. The Legality of the Surrogate Mother Agreement Reviewed from Indonesian Civil Law (2025)








